Accelerator Life Science Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
28
- Portfolio
-
6
- Exits
-
17
Accelerator Life Science Partners General Information
Description
Founded in 2003, Accelerator Life Science Partners is a venture capital firm based in Seattle, Washington. The firm seeks to make investments in early-stage biotech companies.
Contact Information
Website
www.acceleratorlsp.com
Year Founded
2003
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
- 2815 Eastlake Avenue East
- Suite 300
- Seattle, WA 98102
- United States
+1 (206) 000-0000
Accelerator Life Science Partners Investments (28)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| KayoThera | 17-Mar-2022 | Early Stage VC | 000 | Drug Discovery | Startup | 0000000 000000 00.0 |
| 00000000 | 11-Jul-2019 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 00000 00 |
| 000000 00000000000 | 23-Aug-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 00 |
| 00000000 000000000 | 13-Aug-2018 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 00 |
| 00000 | 11-Dec-2017 | 0000 00000 | 00.00 | Other Services (B2C Non-Financial) | Generating Revenue | |
| 00000 000000000000 | 25-Jul-2017 | 00000 00000 | 00.00 | Drug Discovery | Generating Revenue | 00000 00000000 |
| 0000 000000000000 | 18-Jan-2016 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 00 |
| 00000 000000 | 06-Jan-2016 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00000 00 |
| Acylin Therapeutics | 02-Jul-2014 | Secondary Transaction - Private | 00.000 | Drug Discovery | Generating Revenue | 0000 00000000 |
| Theraclone Sciences | 12-Aug-2013 | Later Stage VC | 0000 | Drug Delivery | Out of Business |
Accelerator Life Science Partners Exits (17)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ALSP Orchid Acquisition Corp I | 19-Nov-2021 | IPO | 00000 |
| 0000 000000000000 | 16-May-2021 | 000000000000000000 | 000.00 |
| 00000 000000000000 | 30-Mar-2021 | 000000000000000000 | 00000 |
| 000000 00000000000 | 01-Jul-2020 | 000000000000000000 | |
| 00000 000000 | 14-May-2020 | 000000000000000000 | |
| 0000 000000000000 | 24-Feb-2020 | 000 00 00000000 | |
| 0000000000 0000000 | 09-Jul-2018 | 000000000000000000 | |
| 000000 000000 | 18-Nov-2016 | 000 00 00000000 | |
| MyOptique Group | 30-Sep-2016 | Merger/Acquisition | 00000 |
| Oncofactor | 01-Oct-2015 | Out of Business |
Accelerator Life Science Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Accelerator Life Science Partners Team (25)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Ian Howes | Chief Financial Officer & Managing Director | Seattle, WA | |||
| David Schubert | Chief Operating Officer | 0 | 0 | Seattle, WA | |
| Court Turner JD | Operating Partner & Chief Business Officer | 0 | 0 | 0 | Seattle, WA |
| Andrew Howard Ph.D | Operating Partner | Seattle, WA | |||
| Merika Koday Ph.D | Principal | Seattle, WA |
Accelerator Life Science Partners Co-Investors (17)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| ARCH Venture Partners | 3 | 0 |
|
|
|
| Alexandria Venture Investments | 0 | 0 |
|
|
|
| Watson Fund | 0 | 0 |
|
|
|
| WuXi AppTec | 0 | 0 |
|
|
|
| Johnson & Johnson Innovation - JJDC | 0 | 0 |
|
|